Share
- Release Date: 04/12/12 14:34
- Summary: NTA: MLN: MLN NAV $0.8237 as at 30/11/12
- Price Sensitive: No
- Download Document 1.43KB
MLN
04/12/2012 12:34
NTA
REL: 1234 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8237 as at 30/11/12
MLN NAV $0.8237 as at 30/11/12
Date 30/11/2012 27/11/2012
MLN NAV $0.8237 $0.8190
Share price close $0.69 $0.68
Discount 16% 17%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 30 November 2012 are approximately as
follows:
Biotest (Germany) 6%
Stratec Biomedical (Germany) 4%
Wasion (China) 4%
Wirecard (Germany) 4%
Sarin Technologies (Israel) 4%
BACKGROUND
Marlin Global Limited is a listed investment company that invests in
companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00230651 For:MLN Type:NTA Time:2012-12-04 12:34:12
